Genetic Heterogeneity of HER2 Amplification and Telomere Shortening in Papillary Thyroid Carcinoma
Extensive research is dedicated to understanding if sporadic and familial papillary thyroid carcinoma are distinct biological entities. We have previously demonstrated that familial papillary thyroid cancer (fPTC) cells exhibit short relative telomere length (RTL) in both blood and tissues and that...
Main Authors: | Paola Caria, Silvia Cantara, Daniela Virginia Frau, Furio Pacini, Roberta Vanni, Tinuccia Dettori |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-10-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/17/10/1759 |
Similar Items
-
Breast carcinomas with low amplified/equivocal HER2 by Ish: potential supporting role of multiplex ligation-dependent probe amplification
by: Cristiana Ercolani, et al.
Published: (2017-10-01) -
HER2 Analysis in Sporadic Thyroid Cancer of Follicular Cell Origin
by: Rosaria M. Ruggeri, et al.
Published: (2016-12-01) -
Correlation between HER2 gene amplification and protein overexpression through fluorescence in situ hybridization and immunohistochemistry in breast carcinoma patients
by: R N Makroo, et al.
Published: (2012-01-01) -
Gallbladder Adenocarcinoma, Potential Target for Anti-Her-2 Therapy
by: Ghazi Zafar, et al.
Published: (2020-08-01) -
Revisiting Telomere Shortening in Cancer
by: Keiji Okamoto, et al.
Published: (2019-01-01)